Senti Biosciences, Inc. (SNTI)
1.05
-0.01
(-0.94%)
USD |
NASDAQ |
Dec 30, 16:00
1.06
+0.01
(+0.95%)
After-Hours: 19:26
Senti Biosciences Research and Development Expense (Quarterly): 10.29M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| iBio, Inc. | 3.55M |
| Vor Biopharma, Inc. | 14.14M |
| NovaBay Pharmaceuticals, Inc. | -- |
| Palatin Technologies, Inc. | 2.526M |
| Theriva Biologics, Inc. | 2.551M |